Risk for tuberculosis in child contacts: Development and validation of a predictive score

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 2, 2014, Pages 203-213

  Chan, Pei Chun ^a,b,c   Peng, Steven Shinn Forng ^b,c   Chiou, Mei Yu ^a   Ling, Du Lin ^a   Chang, Luan Yin ^c   Wang, Kwei Feng ^a   Fang, Chi Tai ^b,c   Huang, Li Min ^c  

^a Centers for Disease Control   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Isoniazid preventive therapy; Latent tuberculosis infection; Strategy

Indexed keywords

ISONIAZID;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SCORING SYSTEM; SMEAR; TUBERCULIN TEST; TUBERCULOSIS; VALIDATION STUDY;

ANTIBIOTIC PROPHYLAXIS; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; ISONIAZID; LATENT TUBERCULOSIS; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TAIWAN; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84892635091     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201305-0863OC     Document Type: Article

References (41)

1. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med 2012;367:348-361.
2. National Tuberculosis Controllers Association; Centers for Disease Control and Prevention (CDC). Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep 2005;54:1-47.
3. Comstock GW. Frost revisited: the modern epidemiology of tuberculosis. Am J Epidemiol 1975;101:363-382.
4. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-138.
5. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350:2060-2067.
6. Lo HY, Chou P, Yang SL, Lee CY, Kuo HS. Trends in tuberculosis in Taiwan, 2002-2008. J Formos Med Assoc 2011;110:501-510.
7. Bloss E, Chan PC, Cheng NW, Wang KF, Yang SL, Cegielski P. Increasing directly observed therapy related to improved tuberculosis treatment outcomes in Taiwan. Int J Tuberc Lung Dis 2012;16:462-467.
8. Chan PC, Yang CH, Chang FY. Scaling up of latent tuberculosis infection treatment for close contacts of tuberculosis in Taiwan. J Formos Med Assoc 2011;110:733-736.
9. Chan PC, Chiou MY, Wang KF, Yang CH, Fang CT. Engaging all TB care providers to implement isoniazid preventive therapy nationwide. Int J Tuberc Lung Dis 2011;11:S295-S296.
10. Yang HI, Yuen MF, Chan HL, Han KH, Chen PJ, Kim DY, Ahn SH, Chen CJ, Wong VW, Seto WK; REACH-B Working Group. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol 2011;12:568-574.
11. Chan PC, Peng S S F, Chiou MY, Lu BY, Wang KF, Fang CT, et al. The evaluation of effectiveness for latent TB infection treatment among child contacts in Taiwan. Presented at the 44th Union World Conference. November 3, 2013. Paris, France. Poster discussion PC-824-03.
12. Ling DL, Liaw YP, Lee CY, Lo HY, Yang HL, Chan PC. Contact investigation for tuberculosis in Taiwan contacts aged under 20 years in 2005. Int J Tuberc Lung Dis 2011;15:50-55.
13. Ling DL, Liaw YP, Lo HY, Lee CY, Wang KF, Yang HL, Yang HY, Chan PC. Tuberculosis contact investigation in Taiwan: a 5-year follow-up study. Thoracic Med 2011;26:FA04.
14. Centers for Disease Control, Department of Health. Manual for tuberculosis control. Taipei, Taiwan: CDC [accessed 2013 Oct. 13]. Available from: http://www.cdc.gov. tw/professional/info.aspx?treeid= BEAC9C103DF952C4&nowtreeid= 37E21E0A5DCDB27C&tid=AA8B780D65A0B152
15. Chan PC, Huang LM, Suo J. It is time to deal with latent tuberculosis infection in Taiwan. J Formos Med Assoc 2009;108:901-903.
16. Lee PH, Chang FY. Latent infection treatment to prevent TB transmission in school settings. J Formos Med Assoc 2012;111:525-526.
17. Chan PC, Tsai YF, Feng CF, Lee PH, Wang KF, Yang CH. Treatment of latent tuberculosis infection in Taiwan: the present and future. Taiwan Epidemiology Bulletin 2013;29:40-49.
18. Centers for Disease Control, Department of Health. Taiwan guidelines for TB diagnosis & treatment. 3rd edition. Taipei, Taiwan: CDC; 2008 [accessed 2013 Oct. 13]. Available from: http://www.cdc.gov. tw/uploads/files/1d2c6466- 9702-4e45-a09e-450ca02ca843.pdf
19. Centers for Disease Control. Department of Health, R. O. C. (Taiwan). Taiwan tuberculosis control report 2012. Taipei, Taiwan: CDC; 2012 [accessed 2013 Oct. 13]. Available from: http://www.cdc.gov. tw/uploads/files/201303/ 9ea28ba2-69c7-4f27-af3b-55be5ec7e35c.pdf
20. Veening G J J. Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults. Bull Int Union Tuberc 1968;41:169-171.
21. Pediatric Tuberculosis Collaborative Group. Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents. Pediatrics 2004;114:1175-1201.
22. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011;37:88-99.
23. Chan PC, Yang CH, Chang LY, Wang KF, Kuo YC, Lin CJ, Lee SW, Hsueh PR, Fang CT, Huang LM. Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates. Thorax 2013;68:263-268.
24. Abubakar I, Stagg HR, Whitworth H, Lalvani A. How should I interpret an interferon gamma release assay result for tuberculosis infection? Thorax 2013;68:298-301.
25. Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 2013;41:140-156.
26. Lee MS, Nokes DJ. Predicting and comparing long-term measles antibody profiles of different immunization policies. Bull World Health Organ 2001;79:615-624.
27. Duke T, Mgone CS. Measles: not just another viral exanthem. Lancet 2003;361:763-773.
28. Karp CL. Measles: immunosuppression, interleukin-12, and complement receptors. Immunol Rev 1999;168:91-101.
29. Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, Deeks JJ, Efe S, Staveley I, Ewer K, Lalvani A. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005;366:1443-1451.
30. Yu MC, Bai KJ, Chang JH, Lee CN. Tuberculosis incidence and mortality in aboriginal areas of Taiwan, 1997-2001. J Formos Med Assoc 2004;103:817-823.
31. Chang YM, Shen CK, Chiu CH, Chiang HJ, Lu LC, Liou SH. Burden of tuberculosis among aboriginal and non-aboriginal Taiwanese, 1996-2006. Int J Tuberc Lung Dis 2011;15:471-477.
32. Chan PC, Huang LM, Wu YC, Yang HL, Chang IS, Lu CY, Lee PI, Lee CY, Chang LY. Tuberculosis in children and adolescents, Taiwan, 1996-2003. Emerg Infect Dis 2007;13:1361-1363.
33. Bowerman RJ. Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan. Int J Tuberc Lung Dis 2004;8:1228-1233.
34. Bloss E, Holtz TH, Jereb J, Redd JT, Podewils LJ, Cheek JE, McCray E. Tuberculosis in indigenous peoples in the U. S., 2003-2008. Public Health Rep 2011;126:677-689.
35. Narasimhan P, Wood J, Macintyre CR, Mathai D. Risk factors for tuberculosis. Pulm Med 2013;2013:828939.
36. The Indigenous Peoples Basic Law [accessed 2013 Oct. 13]. Available at: http://law.moj.gov. tw/Eng/LawClass/LawAll.aspx?PCode=D0130003
37. Lienhardt C, Sillah J, Fielding K, Donkor S, Manneh K, Warndorff D, Bennett S, McAdam K. Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in the Gambia, West Africa. Pediatrics 2003;111:e608-e614.
38. Basu Roy R, Sotgiu G, Altet-Gómez N, Tsolia M, Ruga E, Velizarova S, Kampmann B. Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin? A pTB-NET collaborative study. Am J Respir Crit Care Med 2012;186:378-384.
39. Lee M S N, Leung CC, Kam KM, Wong MY, Leung MC, Tam CM, Leung EC. Early and late tuberculosis risks among close contacts in Hong Kong. Int J Tuberc Lung Dis 2008;12:281-287.
40. Triasih R, Rutherford M, Lestari T, Utarini A, Robertson CF, Graham SM. Contact investigation of children exposed to tuberculosis in South East Asia: a systematic review. J Trop Med 2012;2012:301808.
41. Liu PL, Lai AC, Huang YF, Yang CH. Research on the hidden space of mother-child vertical transmission of HIV-the pregnant women with high risk outside the medical network. Taiwan Epidemiology Bulletin 2009;25:754-761.